Get the Stockscreener App
133.54
0.58%
-0.78
Pre-market:
133.25
-0.29
-0.22%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $133.54, with a volume of 478.95K.
It is down -0.58% in the last 24 hours and up +2.85% over the past month.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
See More
Previous Close:
$134.32
Open:
$135.41
24h Volume:
478.95K
Relative Volume:
0.67
Market Cap:
$5.91B
Revenue:
$2.81B
Net Income/Loss:
$-294.68M
P/E Ratio:
-5.8545
EPS:
-22.8098
Net Cash Flow:
$232.59M
1W Performance:
+5.35%
1M Performance:
+2.85%
6M Performance:
+5.54%
1Y Performance:
+14.46%
1-Day Range:
$133.19
$136.69
1-Week Range:
$127.75
$136.69
52-Week Range:
$100.18
$139.67
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
133.54 | 5.91B | 2.81B | -294.68M | 232.59M | -22.81 |
ISRG
Intuitive Surgical Inc
|
427.30 | 151.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
156.30 | 43.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
43.01 | 36.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
66.87 | 32.61B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.75 | 31.88B | 5.54B | 1.52B | 1.74B | 10.37 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Upgrade | BofA Securities | Underperform → Neutral |
| Mar-27-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-27-26 | Upgrade | Needham | Hold → Buy |
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Teleflex Inc. focuses on medical devices and long-term growth - AD HOC NEWS
Teleflex Publishes 2025 Global Impact Report - Business Wire
Teleflex Inc focuses on medical devices as investors watch long term growth - AD HOC NEWS
Teleflex Arrow EZ-IO System from Teleflex Inc.Vascular access tool that is shaping emergency care - AD HOC NEWS
Teleflex Inc. focuses on medical device growth as investors watch US market exposure - AD HOC NEWS
Teleflex Incorporated (TFX) Stock Analysis: Exploring an 8.88% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Teleflex Inc. focuses on specialty medical devices amid steady demand - AD HOC NEWS
The Teleflex Arrow EZ-IO System. A rugged emergency access tool built for seconds - AD HOC NEWS
Teleflex Q1 2026 slides: earnings beat amid margin pressure, buyback starts early - Investing.com
Teleflex stock leans on its medical devices base - AD HOC NEWS
TFX News | TELEFLEX INC (NYSE:TFX) - ChartMill
Teleflex Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Teleflex Dodges Bid to Revive Patent Case Over Laryngoscopes - Bloomberg Law News
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Teleflex Inc. focuses on medical devices as investors watch long-term growth prospects - AD HOC NEWS
Teleflex advances heart scaffold trial, shares trade below recent highs - AD HOC NEWS
Teleflex Inc. stock underperforms Monday when compared to competitors - MarketWatch
Teleflex Incorporated (TFX) Stock Analysis: A Closer Look At Its 12.34% Potential Upside - DirectorsTalk Interviews
Teleflex Incorporated (TFX) Stock Price Today - CoinMarketCap
The UroLift System from Teleflex Inc.minimally invasive relief for BPH patients - AD HOC NEWS
Should Teleflex’s Bioresorbable Scaffold Trial Progress Require Action From Teleflex (TFX) Investors? - simplywall.st
Teleflex focuses on vascular devices, peers show sector momentum - Ad-hoc-news.de
Enterprise value to EBITDA forward of Teleflex Incorporated – NYSE:TFX - TradingView
Enterprise value to EBITDA forward of Teleflex Incorporated – BX:TBH - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporat - The National Law Review
Price to sales forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex (TFX) Could Be 43% Undervalued Following BIOMAG III Study Enrollment - Sahm
Price to sales forward of Teleflex Incorporated – BX:TBH - TradingView
Teleflex Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Teleflex Incorporated Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh - TradingView
Enterprise value to EBIT forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex (TFX) Institutional Ownership 2026 $TFX - MarketBeat
Price to earnings forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex Incorporated Actuals & Estimates (NYSE:TFX) - TradingView
Enterprise value to revenue forward of Teleflex Incorporated – NYSE:TFX - TradingView
TFX Forecast — Price Target — Prediction for 2027 - TradingView
Teleflex launches BIOMAG III trial, analyst consensus on the shares stays cautious - Ad-hoc-news.de
Enterprise value to revenue forward of Teleflex Incorporated – BX:TBH - TradingView
Do Options Traders Know Something About Teleflex Stock We Don't? - TradingView
The Freesolve Resorbable Magnesium Scaffold from Teleflex Inc.global BIOMAG-III trial puts the co - Ad-hoc-news.de
Teleflex Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Teleflex begins enrollment in pivotal resorbable scaffold study By Investing.com - Investing.com Australia
Teleflex begins enrollment in pivotal resorbable scaffold study - Investing.com UK
Teleflex begins enrollment in BIOMAG-III pivotal study - grafa.com
Teleflex Starts Enrollment in Resorbable Magnesium Scaffold Study - Medical Product Outsourcing
Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold - Business Wire
Teleflex reports muted share move, analyst metrics frame the stock - AD HOC NEWS
Teleflex Inc (TFX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Teleflex Inc (TFX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Teleflex Inc (TFX) Shares Fall 4.2% -- What GF Score of 76 Tells Investors - GuruFocus
Teleflex adjusts debt profile with new senior notes, shares in focus on NYSE - AD HOC NEWS
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
2.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):